Ginger.io named to CNBC’s Disruptor50 list
The list includes 50 most disruptive companies changing the business landscape today.
Ginger.io launches Type 2 Diabetes program
The system is designed to allow people living with diabetes a new way to stay in touch with their health, while also being able to contribute to science.
Ginger.io raises $6.5M Series A in a round led by Khosla Ventures
The new money will be used to scale the team, improve the product, and support existing and new partners.
Ginger.io opens West Coast office in San Francisco
Ginger.io is expanding to the West Coast. The new office is located in San Francisco, at 965 Mission. However, Boston has and will continue...
Ginger.io, C3N launch Collaborative Chronic Care Network
The goal is to use smartphones to help doctors passively capture the experiences of adolescents who are managing their inflammatory bowel disease (IBD).
Pipette joins Ginger.io
San Francisco-based Pipette developed technology to enable hospitals and care teams to monitor and educate patients during their recovery.
Ginger.io raises $1.7M seed financing from investors from Boston, New York and San Francisco
The money will be used to grow the technology platform, and ramp up engineering and product development to support early partners.